Cancer Family
Endocrine Neoplasm
CI-CAN-00000015Explore in graph →
Non-malignant764 active trials16 approved drugs64 evidence items
- NCIt
- C3010
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000015Explore in graph →
Clinical trials
2,725 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00028028 | CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00068783 |
| S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer |
| completed |
| Phase 2 |
| 40 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Feb 28, 2013 |
| clinicaltrials |
| NCT00977561 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | terminated | Phase 2 | 9 | PfizerINDUSTRY | 4 | Feb 25, 2013 | clinicaltrials |
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00017199 | PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00305942 | Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 61 | SCRI Development Innovations, LLCOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00017251 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00776295 | Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00055809 | Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00087191 | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | terminated | N/A | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01216267 | Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples | completed | N/A | 200 | University of Western Ontario, CanadaOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01683110 | Expanded Access of Cabozantinib in Medullary Thyroid Cancer | approved for marketing | — | — | ExelixisINDUSTRY | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00068497 | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | N/A | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT01752517 | Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer | unknown | — | 60 | Peking Union Medical College HospitalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00294190 | Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | completed | Phase 2 | 38 | SCRI Development Innovations, LLCOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01071434 | Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors | terminated | — | 5 | Stanford UniversityOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01730417 | Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG(mIBG) | completed | Phase 1 | 12 | Bennett ChinOTHER | 1 | Nov 21, 2012 | clinicaltrials |
| NCT00204373 | Treatment of Zollinger-Ellison Syndrome With Prevacid | completed | Phase 4 | 72 | Charles Mel Wilcox, MDOTHER | 0 | Oct 30, 2012 | clinicaltrials |
| NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | completed | Phase 2 | 80 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00002921 | S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery | terminated | Phase 2 | 13 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 5, 2012 | clinicaltrials |
| NCT01448083 | Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours | unknown | — | 40 | Nuclear Medicine Consultants, Inc.OTHER | 1 | Sep 18, 2012 | clinicaltrials |
| NCT00434109 | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | completed | Phase 2 | 39 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00353015 | Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00065429 | Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | ImmunoGen, Inc.INDUSTRY | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT01635400 | Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer | unknown | Phase 2 | 50 | Zhejiang Cancer HospitalOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01592422 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer | unknown | Phase 2 | 60 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT00324558 | Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) | terminated | Phase 2 | 39 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00088595 | Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors | completed | Phase 2 | 45 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00466856 | Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | terminated | Phase 2 | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT01338090 | 89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors(NETPET) | completed | — | 14 | University Medical Center GroningenOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00436657 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00698516 | Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer | completed | Phase 2 | 50 | GlaxoSmithKlineINDUSTRY | 1 | Mar 27, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00324012 | Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma | completed | Phase 2 | 19 | Rigshospitalet, DenmarkOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00472771 | INNO-206 in Patients With Small Cell Lung Cancer (SCLC) | withdrawn | Phase 2 | 0 | CytRxINDUSTRY | 1 | Feb 9, 2012 | clinicaltrials |
| NCT01510002 | Prophylactic Central Neck Dissection for Papillary Thyroid Cancer | completed | N/A | 640 | Jagiellonian UniversityOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00339131 | ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid | completed | Phase 1 | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 0 | Oct 12, 2011 | clinicaltrials |
| NCT01429766 | A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients | unknown | Phase 2 | 100 | Tata Memorial HospitalOTHER_GOV | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00663429 | Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma | completed | Phase 2 | 10 | Callisto PharmaceuticalsINDUSTRY | 1 | Aug 31, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2013source: clinicaltrials